Benjamin Jackson
Benjamin Jackson is an analyst at Jeffries who has recently gained attention for questioning the decision of Novo Nordisk to appoint Maziar Mike Doustdar as the new CEO. His insights reflect concerns in the financial community regarding the company's strategic choices amidst a challenging market landscape for obesity treatments.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 5.00 | 0.03% | +0% | 67,886,011 | 23,670 | $2,700,000 | 941$ |
| Totals | 1 | 67,886,011 | 23,670 | $2,700,000 | 941$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Benjamin Jackson questioned why Novo Nordisk has decided to appoint an internal candidate to replace Mr Jørgensen.
5